Back to Trades
Yea Christopher
InsiderCIK 0001691102
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 1
- Active
- 2025–2026
Yea Christopher has filed 11 SEC reports (2025–2026), all concentrated in KalVista Pharmaceuticals, Inc. (KALV), totaling $7.7M in disclosed volume. Weighing $0 bought versus $1.7M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Jun 11 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Disposed | $5.5M |
| May 29 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $905.2K |
| May 26 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $63.2K |
| Feb 24 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $67.7K |
| Feb 19 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $16.6K |
| Nov 26 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $58.3K |
| Nov 19 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $38.8K |
| Aug 26 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $26.2K |
| Aug 25 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $31.2K |
| Aug 19 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $34.9K |
| Jul 10 | KALV KalVista Pharmaceuticals, Inc. | Yea Christopher | Insider | Sell | $474.7K |
11 filings